Drug class

Fertility Stimulating Preparations, Non-FSH

"Fertility Stimulating Preparations, Non-FSH" is a standardized compendial drug classification rather than a formal clinical pharmacologic class, primarily used within drug data hierarchies such as First Databank to categorize non-gonadotropin ovulatory stimulants. Read more about Fertility Stimulating Preparations, Non-FSH

8 drugs in this class 7 manufacturers

Advertisement

Drugs in Fertility Stimulating Preparations, Non-FSH

Showing 1–8 of 8 drugs

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
PAR HEALTH USA,

CLOMID (clomiphene citrate)

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
Cosette Pharmaceuticals

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
RISING PHARM

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
ADVAGEN PHARMA

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
Cosette Pharmaceuticals

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
ANI PHARMACEUTI

CLOMIPHENE CITRATE

FERTILITY STIMULATING PREPARATIONS, NON-FSH · INFERTILITY ASSOCIATED WITH ANOVULATION
ACCORD HEALTHCA
Filter & compare in the drug finder → Opens the drug finder with Fertility Stimulating Preparations, Non-FSH preselected. Add indication or manufacturer filters there.

About Fertility Stimulating Preparations, Non-FSH.

"Fertility Stimulating Preparations, Non-FSH" is a standardized compendial drug classification rather than a formal clinical pharmacologic class, primarily used within drug data hierarchies such as First Databank to categorize non-gonadotropin ovulatory stimulants.

Represented predominantly by selective estrogen receptor modulators like clomiphene citrate, these agents function by blocking estrogen receptors at the hypothalamus and pituitary gland, interrupting negative feedback to stimulate endogenous gonadotropin secretion.

Their primary therapeutic role is ovulation induction in patients experiencing anovulatory infertility, most notably polycystic ovary syndrome or unexplained hypothalamic-pituitary-ovarian axis dysfunction.